Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Viral Vectors and Plasmid DNA Manufacturing Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Viral Vectors and Plasmid DNA Manufacturing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (), revenue (Million USD), market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Viral Vectors and Plasmid DNA Manufacturing market competition by top manufacturers/players, with Viral Vectors and Plasmid DNA Manufacturing sales volume, Price (), revenue (Million USD) and market share for each manufacturer/player; the top players including
Aldevron
Eurogentec
Richter-Helm
BioReliance
Biovian
Brammer Bio
Cell and Gene Therapy Catapult
Cobra Biologics
FinVector
FUJIFILM Diosynth Biotechnologies
Lonza
MassBiologics
MolMed
Oxford BioMedica
Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
Spark Therapeutics
UniQure
ViGene Biosciences
Wuxi AppTec
On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into
Plasmid DNA
Viral Vectors
Non-Viral Vectors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing for each application, including
Cancers
Inherited Disorders
Viral Infections
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Report 2017
1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing by Product Category
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Plasmid DNA
1.2.4 Viral Vectors
1.2.5 Non-Viral Vectors
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market by Application/End Users
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Region
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.3 China Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.5 Japan Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.6 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.4.7 India Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Viral Vectors and Plasmid DNA Manufacturing (2012-2022)
1.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)
1.5.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

2 Global Viral Vectors and Plasmid DNA Manufacturing Competition by Players/Suppliers, Type and Application
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Players/Suppliers
2.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Type
2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2012-2017)
2.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)
2.3 Global Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Region
2.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Region (2012-2017)
2.3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Region (2012-2017)
2.4 Global Viral Vectors and Plasmid DNA Manufacturing (Volume) by Application

3 United States Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
3.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
3.1.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
3.1.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
3.1.3 United States Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
3.2 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Players
3.3 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
3.4 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

4 China Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
4.1 China Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
4.1.1 China Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
4.1.2 China Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
4.1.3 China Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
4.2 China Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Players
4.3 China Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
4.4 China Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

5 Europe Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
5.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
5.1.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
5.1.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
5.1.3 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
5.2 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Players
5.3 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
5.4 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

6 Japan Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
6.1 Japan Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
6.1.1 Japan Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
6.1.2 Japan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
6.1.3 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
6.2 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Players
6.3 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
6.4 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

7 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
7.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
7.1.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
7.2 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Players
7.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
7.4 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

8 India Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
8.1 India Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
8.1.1 India Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
8.1.2 India Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
8.1.3 India Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
8.2 India Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Players
8.3 India Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Type
8.4 India Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share by Application

9 Global Viral Vectors and Plasmid DNA Manufacturing Players/Suppliers Profiles and Sales Data
9.1 Aldevron
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Eurogentec
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Richter-Helm
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 BioReliance
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Biovian
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Brammer Bio
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Cell and Gene Therapy Catapult
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Cobra Biologics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 FinVector
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 FUJIFILM Diosynth Biotechnologies
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Lonza
9.12 MassBiologics
9.13 MolMed
9.14 Oxford BioMedica
9.15 Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
9.16 Spark Therapeutics
9.17 UniQure
9.18 ViGene Biosciences
9.19 Wuxi AppTec

10 Viral Vectors and Plasmid DNA Manufacturing Maufacturing Cost Analysis
10.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
10.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)
14.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Viral Vectors and Plasmid DNA Manufacturing Price and Trend Forecast (2017-2022)
14.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Viral Vectors and Plasmid DNA Manufacturing Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2017-2022)
14.3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2017-2022)
14.3.3 Global Viral Vectors and Plasmid DNA Manufacturing Price Forecast by Type (2017-2022)
14.4 Global Viral Vectors and Plasmid DNA Manufacturing Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37999

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 115

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)